Pizzuti Dana — SEC Form 4 filings
SEC reporting owner CIK 1948238. 17 Form 4 filings on record with FilingPulse; latest filed 2025-12-03.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-03-06 to 2025-12-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 14 filings — 146,721 shares, $6,141,787 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 30,000 shares @ $30.43 ($912,900) in Crinetics Pharmaceuticals, Inc., filed 2025-08-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | 17 | — | 18 legs · 146,721 sh · $6,141,787 | 33 |
Form 4 filings — Pizzuti Dana
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-03 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 5,000 @ $16.89 · Sale (S): 5,000 @ $45.02 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 5,000 @ $16.89 · Sale (S): 4,900 @ $42.65 · Sale (S): 100 @ $43.27 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 5,000 @ $16.89 · Sale (S): 5,000 @ $41.81 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 5,000 @ $16.89 · Sale (S): 5,000 @ $32.10 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-08-26 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 30,000 @ $16.89 · Sale (S): 30,000 @ $30.43 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 6,492 @ $29.18 | EDGAR |
| 2025-03-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 2,388 @ $34.17 · Sale (S): 127 @ $34.83 | EDGAR |
| 2025-02-24 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 43,000 @ $0 · Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 5,000 @ $16.89 · Sale (S): 5,000 @ $39.07 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 15,000 @ $16.89 · Sale (S): 15,000 @ $52.09 · Option exercise (M): 2,500 @ $19.64 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 14,375 @ $16.89 · Sale (S): 14,375 @ $54.63 · Option exercise (M): 14,375 (derivative) @ $0 | EDGAR |
| 2024-07-05 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 14,375 @ $16.89 · Sale (S): 14,375 @ $44.87 · Option exercise (M): 14,375 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 9,500 @ $16.89 · Sale (S): 9,500 @ $45.73 · Option exercise (M): 9,500 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 14,375 @ $16.89 · Sale (S): 14,375 @ $44.47 · Option exercise (M): 14,375 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 4,375 @ $16.89 · Sale (S): 4,375 @ $45.89 · Option exercise (M): 10,000 @ $16.89 · Sale (S): 10,000 @ $43.28 · Sale (S): 714 @ $43.69 · Option exercise (M): 4,375 (derivative) @ $0 · +1 more | EDGAR |
| 2024-03-20 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Tax withholding (F): 411 @ $38.14 | EDGAR |
| 2024-03-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 23,000 @ $0 · Grant/award (A): 87,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1948238 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →